Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Shijiazhuang No.4 Pharmaceutical Co., Ltd., commonly referred to as Shijiazhuang No.4 Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shijiazhuang, China. Established in 1956, the company has evolved significantly, focusing on the research, development, and manufacturing of a diverse range of pharmaceutical products, including APIs (Active Pharmaceutical Ingredients) and finished dosage forms. With a strong presence in both domestic and international markets, Shijiazhuang No.4 Pharma is recognised for its commitment to quality and innovation. The company’s core offerings include a variety of therapeutic agents, particularly in the fields of cardiovascular and anti-infective medications, distinguished by their high efficacy and safety profiles. Over the years, Shijiazhuang No.4 Pharma has achieved notable milestones, solidifying its position as a trusted supplier in the global pharmaceutical landscape.
DitchCarbon Score
How does Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s reported carbon emissions
Shijiazhuang No.4 Pharmaceutical Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Shijiazhuang No.4 Pharmaceutical aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious targets for carbon reduction. In summary, without available emissions data or climate commitments, Shijiazhuang No.4 Pharmaceutical Co., Ltd. currently lacks transparency regarding its carbon footprint and climate strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shijiazhuang No.4 Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
